Edesa Biotech, Inc.

📍 Markham, Canada🗓 Founded 2015👥 21 employees💰 Last funded 2021
Biotechnology Research🌐 edesabiotech.com
Website LinkedIn
Edesa Biotech, Inc. (Nasdaq: EDSA) is a clinical-stage biopharmaceutical company developing innovative ways to treat inflammatory and immune-related diseases. Our most advanced drug candidate is EB05 (paridiprubart), a monoclonal antibody developed for acute and chronic disease indications that involve dysregulated innate immune responses. Edesa is currently evaluating EB05 in a Phase 3 study as a potential treatment for Acute Respiratory Distress Syndrome (ARDS), a life-threatening form of respiratory failure. In addition, Edesa is developing an sPLA2 inhibitor, EB01, as a topical treatment for chronic Allergic Contact Dermatitis (ACD), a common occupational skin condition. The company has also received regulatory approval to conduct a Phase 2 trial its EB06 monoclonal antibody as a treatment for vitiligo, a life-altering autoimmune disease that causes skin to lose its color in patches. We also are planning a future Phase 2 study of paridiprubart for systemic sclerosis (scleroderma), an autoimmune rheumatic disorder that causes fibrosis (scarring/hardening) of skin and internal organs.
3
Total investors
2
Early stage
0
Mid stage
1
Late stage
2015
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
Canada
1
Spain
1
United States
1
Investor activity2017–2021 · investors recorded per year
2017220211
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Edesa Biotech, Inc.?
Edesa Biotech, Inc. has 3 investors on record on gritt.io, including 2 early-stage backers and 1 late-stage investors.
When did Edesa Biotech, Inc. last raise funding?
The most recent investment in Edesa Biotech, Inc. recorded on gritt.io was in 2021.
When was Edesa Biotech, Inc. founded?
Edesa Biotech, Inc. was founded in 2015.
What industry is Edesa Biotech, Inc. in?
Edesa Biotech, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Edesa Biotech, Inc. based?
Edesa Biotech, Inc. is headquartered in Markham, Canada.